Pharmacyclics (PCYC) Get Boost Following New Executive Addition
Tweet Send to a FriendGet Alerts PCYC Hot Sheet
Trade PCYC Now!
Pharmacyclics, Inc. (Nasdaq: PCYC) is getting a boost Wednesday following a positive management change announced late Tuesday night.
The Company added Josh Brumm from ZELTIQ Aesthetics, Inc (Nasdaq: ZLTQ) as its new EVP of Finance. Pharmacyclics said Brumm will have global responsibility for corporate finance, accounting, investor relations and IT.
Shares of Pharmacyclics are up nearly 4 percent in morning trade.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The Company added Josh Brumm from ZELTIQ Aesthetics, Inc (Nasdaq: ZLTQ) as its new EVP of Finance. Pharmacyclics said Brumm will have global responsibility for corporate finance, accounting, investor relations and IT.
Shares of Pharmacyclics are up nearly 4 percent in morning trade.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Tesla (TSLA) Ramps Higher (GM)
- U.S. Video Game Sales Slip 25% in May as Consumers Dellay Purchases, Move to Digital
- UPDATE: Herbalife (HLF) Sees Intra-Day Pressure
Create E-mail Alert Related Categories
Insiders' Blog, Management Changes
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
